[1]
Sulaymanov D.A. и Yigitaliev A.B., «THE SIGNIFICANCE OF KEY IMMUNE CYTOKINES AS DIAGNOSTIC AND PROGNOSTIC MARKERS IN THYROID CANCER DURING TREATMENT», ОМ, т. 1, вып. 16, сс. 18–23, окт. 2026, просмотрено: ноя. 19, 2026. доступно на: https://journals.tnmu.uz/index.php/tas/article/view/7008